The Cambridge, UK and Holliston, MA, US-based firm says the product is easy to use. It features an on/off switch that allows the lid to be closed without starting the unit and when the lid is opened, the centrifuge stops automatically.
The three rotors include a 6-place rotor for 1.5ml tubes, a 0.2ml PCR strip rotor, and a 1x3in slide rotor. A maximum speed of 6,000rpm/2,000 x g is perfect for quickly spinning down samples, in micro gel filtration applications and for micro-volume centrifugation, the company says.
John Attwood, director of sales and marketing at Scie-Plas, said: ‘The mini centrifuge has been developed to complement our wide range of electrophoresis reagents, buffers and equipment, from transilluminators and blotting units to gel documentation systems.
‘The new mini centrifuge is a highly versatile sample preparation tool for every laboratory bench.’
Scie-Plas puts a new spin on mini centrifuges
Compact model is fitted with three rotors for bioscience research use
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Read moreHans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region